These Money Losses Won't Help You at Tax Time
How to Save and Invest for a House Down Payment
Are Grocery Store Customer Surveys Worth Your Time?
Week's Winners and Losers: iPhone Rings, Disney Disconnects
Today's Perilous Reversal Stock: Sarepta Therapeutics (SRPT)
Bank of America Downgrades Sarepta Therapeutics To Neutral
Sarepta Therapeutics Inc (SRPT) Will File NDA; Analysts Have Mixed Ratings
Wednesday's Pre-Market Insights: Yahoo! Inc. ...
Analysts See More Upside For Sarepta Therapeutics
Sarepta to Finish Eteplirsen Regulatory Filing by Mid-15 - Analyst Blog
Sarepta Explodes On Monster Volume Following Progress With FDA
Wednesday Sector Leaders: Biotechnology, Television & Radio Stocks
Why Shares of Sarepta Therapeutics Skyrocketed Today
Sarepta Therapeutics (SRPT) Stock Soars Following Positive Meeting With FDA